期刊文献+

替考拉宁致血液透析患者心动过缓1例 被引量:2

Teicoplanin to Hemodialysis Patients with Bradycardia Clinical Analysis
原文传递
导出
摘要 笔者分析1例血液透析患者予替考拉宁抗革兰阳性菌感染的治疗过程中出现心动过缓的原因,从而提醒血液透析患者在使用替考拉宁期间应密切监测心率,以使临床用药更加安全、有效、合理。 The analysis of 1 cases of hemodialysis patients treated with teicoplanin against gram positive bacteria infection in leather treatment process occurs in the Heartbeat slow reason,to remind the hemodialysis patients should be closely monitored heart rate in the use of teicoplanin period,to make the clinical medication safety,more ef ective, reasonable.
出处 《中国药物经济学》 2014年第10期33-34,共2页 China Journal of Pharmaceutical Economics
关键词 替考拉宁 血液透析 心动过缓 Teicoplanin Hemodialysis Bradycardia
  • 相关文献

参考文献5

二级参考文献12

  • 1Verbist L,Tjandramaga B, Hendrickx B, et al. In vitro activity and human pharmacokinetics of teicoplanin [J]. Antimicrob Agents Chemother,1984, 26 (6): 881-885.
  • 2Rowland M. Clinical pharmacokinetics of teicoplanin[J]. Clin Pharmacokinet, 1990,18 (3) .. 184-189.
  • 3Tarral E, Jehl F, Tarral A, et al. Pharmacokinetics of teicoplanin in children[J]. J Antimicrob Chemother, 1988,21 Suppl A:47-52.
  • 4Lukas JC, Karikas G, Gazouli M, et al. Pharmacokinetics of teicoplanin in an ICU population of children and infants [J]. Pharmaceutical Research, 2004, 21 (11) :2064-2069.
  • 5Dufort Gustavo, Ventura Clara, Olive Teresa, et al. Teicoplanin pharmacokinetics in pediatric patients [J]. Pediatric Infectious Disease Journal,1996, 15 (6):494-496.
  • 6Stamatiadis D, Papaioannou MG, Giamaretlos-Bourboulis EJ, et al. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis [J]. Peritoneal Dialysis International,2003,23 (2) :127-131.
  • 7Steer JA, Papini RPG, Wilson APR, et al. Pharmacokinetics of a single dose of teieoplanin in burn patients [J]. Journal of Antimicrobial Chemotherapy, 1996, 37 (3) :545-549.
  • 8Bonati M, Traina GL, Villa G, et al. Teicoplanin pharmacokinetics in patients with chronic renal failure[J]. Clin Pharmacokinet, 1987,12 (4) : 292-297.
  • 9Federieo P, Lofts B, Pierluigi V, et al. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose [J]. Journal of Antimierobial Chemotherapy, 2003,2 (51):971-975.
  • 10Masaki S, Kingo C, Takafumi S, et al. Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level[J]. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases, 2006,12:185-189.

共引文献96

同被引文献28

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部